| 000 | 01186 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515210559.0 | ||
| 264 | 0 | _c20100520 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1520-5711 | ||
| 024 | 7 |
_a10.1080/10543400902964167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMasaki, Nobuyuki | |
| 245 | 0 | 0 |
_aOptimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials. _h[electronic resource] |
| 260 |
_bJournal of biopharmaceutical statistics _cJul 2009 |
||
| 300 |
_a721-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 | _aSample Size |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKoyama, Tatsuki | |
| 700 | 1 | _aYoshimura, Isao | |
| 700 | 1 | _aHamada, Chikuma | |
| 773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 19 _gno. 4 _gp. 721-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543400902964167 _zAvailable from publisher's website |
| 999 |
_c19551859 _d19551859 |
||